对COVID-19的Ivermectin重用:药理学和文献计量分析
Maresa Dulle1, Roland Seifert2
1Institute of Pharmacology, Hannover Medical School, Carl-Neuberg-Str. 1, D-30625, Hannover, Germany.
Naunyn-Schmiedeberg's archives of pharmacology
|May 6, 2025
概括
这项研究发现,许多备受引用的COVID-19的ivermectin研究缺乏严格性和数据,推动了没有支持的假设. 这凸显了在卫生危机期间,错误的研究对科学数据库和公共健康的风险.
科学领域:
- 医学研究 医学研究
- 药理学 药理学是指药理学的学科.
- 公共卫生 公共卫生
背景情况:
- 随着COVID-19大流行,全球都在寻找有效的SARS-CoV-2治疗方法进行研究.
- 一种抗寄生虫药物伊弗梅克因其对SARS-CoV-2的假设抗病毒特性而引起了人们的注意.
- 政治和社会因素影响了ivermectin作为COVID-19替代品的推广,特别是在奥地利和美国.
研究的目的:
- 批判性地分析COVID-19有争议的使用ivermectin.
- 在疫情期间检查艾弗梅克研究的出版趋势和科学质量.
- 调查社会政治动态对研究出版实践的影响.
主要方法:
- 在PubMed数据库中搜索2020年1月至2022年12月的"ivermectin"和"COVID-19"出版物.
- 对353篇出版物的科学质量,方法论严谨性和偏见进行了分析.
- 评估预印稿,引用趋势,资金来源和社会政治影响.
主要成果:
- 许多备受引用的ivermectin研究显示出方法上的弱点和数据缺口.
- 关于ivermectin疗效的假设的研究传播缺乏实质性的经验支持.
- 社会政治动态影响了出版趋势和研究成果的传播.
结论:
- 严格的质量控制对于科学研究至关重要,尤其是在卫生危机期间.
- 方法上有缺陷的研究对科学完整性和公共健康构成长期风险.
- 该研究强调了在公共卫生挑战中对科学文献进行批判性评估的必要性.
相关概念视频
Drug Discovery: Overview
7.1K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.1K
Preclinical Development: Overview
4.0K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.0K
Pharmacovigilance
732
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
732
Structure-Activity Relationships and Drug Design
420
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
420
Cancer Therapies
7.4K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.4K


